0001001233 2026-06-18 2026-06-18 NASDAQ 0001001233 8-K/A true 2026-06-18 SANGAMO THERAPEUTICS, INC. DE 000-30171 68-0359556 501 Canal Blvd. Richmond CA 94804 510 970-6000 false false false false Common Stock, $0.01 par value per share SGMO false Sangamo Therapeutics, Inc. is filing this Amendment No. 1 to its Current Report on Form 8-K (this “Amendment”), originally filed with the Securities Exchange Commission on June 23, 2026 (the “Original 8-K”), solely to file exhibits 2.1 and 2.2. This Amendment does not amend or change any of the information previously disclosed in the Original 8-K. Interested parties should refer to the Original 8-K for Items 1.01, 1.03, 2.03 and 2.05.